Search Results

Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation

Authors: Carpi, A.; Nicolini, A.; Antonelli, A.; Ferrari, P.; Rossi, G.

Source: Current Cancer Drug Targets, Volume 9, Number 8, December 2009 , pp. 888-903(16)

Publisher: Bentham Science Publishers

Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials

Author: Gnant, M.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 824-833(10)

Publisher: Bentham Science Publishers

A Frailty-Model-Based Approach to Estimating the Age-Dependent Penetrance Function of Candidate Genes Using Population-Based Case-Control Study Designs: An Application to Data on the BRCA1 Gene

Authors: Chen, Lu; Hsu, Li; Malone, Kathleen

Source: Biometrics, Volume 65, Number 4, December 2009 , pp. 1105-1114(10)

Publisher: Blackwell Publishing

Clinical Management Update: Evaluation and Management of Older Patients with Breast Cancer

Author: Owusu, Cynthia

Source: Journal of the American Geriatrics Society, Volume 57, Supplement 2, December 2009 , pp. 250-252(3)

Publisher: Blackwell Publishing

The Yale University Experience of Early-Stage Invasive Lobular Carcinoma (ILC) and Invasive Ductal Carcinoma (IDC) Treated with Breast Conservation Treatment (BCT): Analysis of Clinical-Pathologic Features, Long-Term Outcomes, and Molecular Expression of COX-2, Bcl-2, and p53 as a Function of Histology

Authors: Moran, Meena S.; Yang, Qifeng; Haffty, Bruce G.

Source: The Breast Journal, Volume 15, Number 6, November/December 2009 , pp. 571-578(8)

Publisher: Blackwell Publishing

Dietary patterns, risk and prognosis of breast cancer

Authors: Thomson, Cynthia A; Thompson, Patricia A

Source: Future Oncology, Volume 5, Number 8, October 2009 , pp. 1257-1269(13)

Publisher: Future Medicine

The Economic Value of Primary Prophylaxis Using Pegfilgrastim Compared with Filgrastim in Patients with Breast Cancer in the UK

Authors: Liu, Zhimei; Doan, Quan V.; Malin, Jennifer; Leonard, Robert

Source: Applied Health Economics and Health Policy, Volume 7, Number 3, 1 September 2009 , pp. 193-205(13)

Publisher: Adis International

Evaluation of missing data imputation in longitudinal cohort studies in breast cancer survival

Authors: Fernandes, Ana S.; Fonseca, Jose M.; Jarman, Ian H.; Etchells, Terence A.; Lisboa, Paulo J.G.; Biganzoli, Elia; Bajdik, Chris

Source: International Journal of Knowledge Engineering and Soft Data Paradigms, Volume 1, Number 3, 3 October 2009 , pp. 257-276(20)

Publisher: Inderscience Publishers

A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer

Authors: Colleoni, M.; Bagnardi, V.; Rotmensz, N.; Dellapasqua, S.; Viale, G.; Pruneri, G.; Veronesi, P.; Torrisi, R.; Luini, A.; Intra, M.; Galimberti, V.; Montagna, E.; Goldhirsch, A.

Source: Annals of Oncology, Volume 20, Number 7, 10 July 2009 , pp. 1178-1184(7)

Publisher: Oxford University Press

A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy

Authors: Guarneri, V.; Piacentini, F.; Ficarra, G.; Frassoldati, A.; D'Amico, R.; Giovannelli, S.; Maiorana, A.; Jovic, G.; Conte, P.

Source: Annals of Oncology, Volume 20, Number 7, 10 July 2009 , pp. 1193-1198(6)

Publisher: Oxford University Press

Letrozole: A Review of its Use in the Treatment of Postmenopausal Women with Hormone-Responsive Early Breast Cancer

Author: Keating, Gillian M.

Source: Drugs, Volume 69, Number 12, 20 August 2009 , pp. 1681-1705(25)

Publisher: Adis International

Estrogen receptor β- an independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?

Authors: MÆHLE, BJØRN O.; COLLETT, KARIN; TRETLI, STEINAR; AKSLEN, LARS A.; GROTMOL, TOM

Source: Apmis, Volume 117, Number 9, September 2009 , pp. 644-650(7)

Publisher: Blackwell Publishing

The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004

Author: Lichtenberg, Frank

Source: Economics of Innovation and New Technology, Volume 18, Number 5, 2009 , pp. 407-428(22)

Publisher: Routledge, part of the Taylor & Francis Group

T1N0 Triple Negative Breast Cancer: Risk of Recurrence and Adjuvant Chemotherapy

Authors: Kaplan, Henry G.; Malmgren, Judith A.; Atwood, Mary

Source: The Breast Journal, Volume 15, Number 5, September/October 2009 , pp. 454-460(7)

Publisher: Blackwell Publishing

A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin : a prospective randomized controlled trial of the ELYPSE study group

Authors: Ray-Coquard, I.; Dussart, S.; Goillot, C.; Mayeur, D.; Debourdeau, P.; Ghesquieres, H.; Bachelot, T.; Le Cesne, A.; Anglaret, B.; Agostini, C.; Guastalla, J.-P.; Lancry, L.; Biron, P.; Desseigne, F.; Blay, J.-Y.

Source: Annals of Oncology, Volume 20, Number 6, 13 June 2009 , pp. 1105-1112(8)

Publisher: Oxford University Press

Physical Activity, Weight Control, and Breast Cancer Risk and Survival: Clinical Trial Rationale and Design Considerations

Authors: Ballard-Barbash, Rachel; Hunsberger, Sally; Alciati, Marianne H.; Blair, Steven N.; Goodwin, Pamela J.; McTiernan, Anne; Wing, Rena; Schatzkin, Arthur

Source: Journal of the National Cancer Institute, Volume 101, Number 9, 6 May 2009 , pp. 630-643(14)

Publisher: Oxford University Press

Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasis

Authors: Coltelli, Luigi; Allegrini, Giacomo; Orlandi, Paola; Giuntini, Nicola; Alì, Greta; Fioravanti, Anna; Bona, Eleonora; Barletta, Maria Teresa; Fontanini, Gabriella; Tacca, Mario Del; Danesi, Romano; Falcone, Alfredo; Bocci, Guido

Source: Pharmacogenomics, Volume 10, Number 8, August 2009 , pp. 1225-1229(5)

Publisher: Future Medicine

Tissue microarray-based study of patients with lymph node-negative breast cancer shows that HER2/neu overexpression is an important predictive marker of poor prognosis

Authors: Choi, Y. H.; Ahn, J. H.; Kim, S.-B.; Jung, K.-H.; Gong, G.-Y.; Kim, M.-J.; Son, B.-H.; Ahn, S.-H.; Kim, W. K.

Source: Annals of Oncology, Volume 20, Number 8, 22 August 2009 , pp. 1337-1343(7)

Publisher: Oxford University Press

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up

Authors: Colleoni, M.; Sun, Z.; Martinelli, G.; Basser, R. L.; Coates, A. S.; Gelber, R. D.; Green, M. D.; Peccatori, F.; Cinieri, S.; Aebi, S.; Viale, G.; Price, K. N.; Goldhirsch, A.

Source: Annals of Oncology, Volume 20, Number 8, 22 August 2009 , pp. 1344-1351(8)

Publisher: Oxford University Press

Management of long-bone metastases: a surgical perspective

Authors: Al-Ghamdi, Ahmed; Hings, Ingrid; Turcotte, Robert E

Source: Aging Health, Volume 5, Number 3, June 2009 , pp. 313-321(9)

Publisher: Future Medicine